760 related articles for article (PubMed ID: 9134653)
1. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
2. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
[TBL] [Abstract][Full Text] [Related]
3. Plasmin inhibition of thrombin-induced platelet aggregation.
Miller JL; Katz AJ; Feinstein MB
Thromb Diath Haemorrh; 1975 Apr; 33(2):286-309. PubMed ID: 124475
[TBL] [Abstract][Full Text] [Related]
4. Contrasting effects of thrombin and the thrombin receptor peptide, SFLLRN, on aggregation and release of 14C-serotonin by human platelets pretreated with chymotrypsin or serratia marcescens protease.
Kinlough-Rathbone RL; Perry DW; Packham MA
Thromb Haemost; 1995 Jan; 73(1):122-5. PubMed ID: 7740483
[TBL] [Abstract][Full Text] [Related]
5. Effects of tris on responses of human and rabbit platelets to aggregating agents.
Packham MA; Guccione MA; Nina M; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1984 Apr; 51(2):140-4. PubMed ID: 6429880
[TBL] [Abstract][Full Text] [Related]
6. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Res; 1999 Sep; 95(6):315-23. PubMed ID: 10527409
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of thrombin-degranulated human platelets: development of a method that does not use proteolytic enzymes for deaggregation.
Kinlough-Rathbone RL; Packham MA; Guccione MA; Richardson M; Harfenist EJ; Mustard JF
Thromb Haemost; 1991 Apr; 65(4):403-10. PubMed ID: 2057923
[TBL] [Abstract][Full Text] [Related]
8. Degranulation of human platelets by the thrombin receptor peptide SFLLRN: comparison with degranulation by thrombin.
Kinlough-Rathbone RL; Perry DW; Guccione MA; Rand ML; Packham MA
Thromb Haemost; 1993 Dec; 70(6):1019-23. PubMed ID: 8165594
[TBL] [Abstract][Full Text] [Related]
9. Effects of plasmin on rabbit platelets.
Guccione MA; Kinlough-Rathbone RL; Packham MA; Harfenist EJ; Rand ML; Greenberg JP; Perry DW; Mustard JF
Thromb Haemost; 1985 Feb; 53(1):8-14. PubMed ID: 3158094
[TBL] [Abstract][Full Text] [Related]
10. Unexpected effects of aurin tricarboxylic acid on human platelets.
Kinlough-Rathbone RL; Packham MA
Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
[TBL] [Abstract][Full Text] [Related]
11. Probenecid inhibits platelet responses to aggregating agents in vitro and has a synergistic inhibitory effect with penicillin G.
Packham MA; Rand ML; Perry DW; Ruben DH; Kinlough-Rathbone RL
Thromb Haemost; 1996 Aug; 76(2):239-44. PubMed ID: 8865538
[TBL] [Abstract][Full Text] [Related]
12. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
13. Effect of the concentration of Ca2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents.
Packham MA; Bryant NL; Guccione MA; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1989 Nov; 62(3):968-76. PubMed ID: 2512683
[TBL] [Abstract][Full Text] [Related]
14. Exposure of human platelets to plasmin results in the expression of irreversibly active fibrinogen receptors.
Rabhi-Sabile S; Pidard D
Thromb Haemost; 1995 Apr; 73(4):693-701. PubMed ID: 7495081
[TBL] [Abstract][Full Text] [Related]
15. Enhanced increases in cytosolic Ca2+ in ADP-stimulated platelets from patients with delta-storage pool deficiency--a possible indicator of interactions between granule-bound ADP and the membrane ADP receptor.
Lages B; Weiss HJ
Thromb Haemost; 1997 Feb; 77(2):376-82. PubMed ID: 9157599
[TBL] [Abstract][Full Text] [Related]
16. Effects of thrombin and the thrombin receptor activating peptide, SFLLRN, on redistribution of platelet alpha-granule contents are similar and independent of the extent of thromboxane formation.
Suzuki H; Packham MA; Kinlough-Rathbone RL
Exp Mol Pathol; 1995 Feb; 62(1):63-72. PubMed ID: 7556592
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
[TBL] [Abstract][Full Text] [Related]
18. Effect of amino sugars on platelet aggregation and on fibrinogen binding.
Kinlough-Rathbone RL; Packham MA; Mustard JF
Thromb Haemost; 1984 Aug; 52(1):75-80. PubMed ID: 6495268
[TBL] [Abstract][Full Text] [Related]
19. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin.
McNicol A; Robson CA
J Pharmacol Exp Ther; 1997 May; 281(2):861-7. PubMed ID: 9152395
[TBL] [Abstract][Full Text] [Related]
20. Properties of washed human platelets.
Kinlough-Rathbone RL; Mustard JF; Packham MA; Perry DW; Reimers HJ; Cazenave JP
Thromb Haemost; 1977 Apr; 37(2):291-308. PubMed ID: 327607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
